Current Development of siRNA Bioconjugates: From Research to the Clinic
Author:
Funder
Russian Science Foundation
Publisher
Frontiers Media SA
Subject
Pharmacology (medical),Pharmacology
Reference261 articles.
1. Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis;Adams;N. Engl. J. Med.,2018
2. Modulation of thermal stability can enhance the potency of siRNA;Addepalli;Nucleic Acids Res.,2010
3. A combinatorial library of lipid-like materials for delivery of RNAi therapeutics;Akinc;Nat. Biotechnol.,2008
4. Multivalent cyclic RGD conjugates for targeted delivery of small interfering RNA;Alam;Bioconjug. Chem.,2011
5. De novo design of a tumor-penetrating peptide;Alberici;Cancer Res.,2013
Cited by 171 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Silence is not always golden: A closer look at potential environmental and ecotoxicological impacts of large-scale dsRNA application;Science of The Total Environment;2024-11
2. Recent advancements in small interfering RNA based therapeutic approach on breast cancer;European Journal of Pharmacology;2024-10
3. Deciphering the role of siRNA in anxiety and depression;European Journal of Pharmacology;2024-10
4. Advancing cancer treatments: The role of oligonucleotide-based therapies in driving progress;Molecular Therapy - Nucleic Acids;2024-09
5. Structure–Activity Relationship of Antibody–Oligonucleotide Conjugates: Evaluating Bioconjugation Strategies for Antibody–siRNA Conjugates for Drug Development;Journal of Medicinal Chemistry;2024-08-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3